One of the key challenges of the modern genomics era is studying the thousands of genes in a single human cell at scale. To ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Ubiquitin-specific peptidase 22 (USP22) is identified as a key chromatin-based barrier to human iPSC derivation through a chromatin-focused CRISPR-Cas9 screen. Here, the authors establish an EV ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...

A research team investigates how genome editing can be harnessed to accelerate cassava breeding and improve key traits.

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases.

Over the past 15 years, developments in the gene-editing technique known as CRISPR-Cas9 have produced significant new ...

Screen protectors aren't just about shielding your device. Some offer blue light filtering, anti-glare coatings, and privacy features. Our experts tested a variety of iPad screen protectors to ...

We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other shorted stocks in 2025.